Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-080825
Filing Date
2025-08-20
Accepted
2025-08-20 14:09:54
Documents
1
Period of Report
2025-08-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2524007-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2524007-1_4seq1.xml 4 3697
  Complete submission text file 0001104659-25-080825.txt   5141
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address VOYAGER THERAPEUTICS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Ferguson Toby (Reporting) CIK: 0002015616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37625 | Film No.: 251236000